- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 181 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- November 2025
- 187 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2025
- 183 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2025
- 184 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more